
Newly public Beta Bionics reports sales surge; Dexcom hires CCO
Beta Bionics reported its first quarterly results as a public company. Sales jumped 145% to $20.4 million in the fourth quarter, coming in 2% above the consensus estimate of Wall Street analysts, Leerink Partners said in a Wednesday note to investors. The …